Evidence map›Paper›PMID 40723999›Full record

ArticleAntibiotics (Basel, Switzerland)2025

Halicin: A New Approach to Antibacterial Therapy, a Promising Avenue for the Post-Antibiotic Era.

Imane El Belghiti, Omayma Hammani, Fatima Moustaoui, Mohamed Aghrouch, Zohra Lemkhente, Fatima Boubrik, Ahmed Belmouden

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Frontiers in bioinformatics · 2026
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Imane El BelghitiLaboratory of Cellular Biology and Molecular Genetics, Faculty of Sciences, Ibn Zohr University, Agadir 80000, Morocco.
Omayma HammaniLaboratory of Cellular Biology and Molecular Genetics, Faculty of Sciences, Ibn Zohr University, Agadir 80000, Morocco.
Fatima MoustaouiLaboratory of Cellular Biology and Molecular Genetics, Faculty of Sciences, Ibn Zohr University, Agadir 80000, Morocco.
Mohamed AghrouchLaboratory of Biological and Medical Analyses of the Hassan II Hospital, Agadir 80000, Morocco.
Zohra LemkhenteLaboratory of Medical-Surgical, Biomedicine and Infectiology Research, Faculty of Medicine and Pharmacy, Ibn Zohr University, Agadir 80000, Morocco.
Fatima BoubrikLaboratory of Cellular Biology and Molecular Genetics, Faculty of Sciences, Ibn Zohr University, Agadir 80000, Morocco.
Ahmed BelmoudenLaboratory of Cellular Biology and Molecular Genetics, Faculty of Sciences, Ibn Zohr University, Agadir 80000, Morocco.ORCID 0000-0003-2553-8387

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial resistanceartificial intelligencehalicinminimum inhibitory concentrationmultidrug-resistant bacteriarepurposed drug

Identifiers

PMID40723999
PMCPMC12291912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.